Multiplex Serum Cytokine Immunoassay Using Nanoplasmonic Biosensor Microarrays
- 20 March 2015
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 9 (4) , 4173-4181
Abstract
Precise monitoring of the rapidly changing immune status during the course of a disease requires multiplex analysis of cytokines from frequently sampled human blood. However, the current lack of rapid, multiplex, and low volume assays makes immune monitoring for clinical decision-making (e.g., critically ill patients) impractical. Without such assays, immune monitoring is even virtually impossible for infants and neonates with infectious diseases and/or immune mediated disorders as access to their blood in large quantities is prohibited. Localized surface plasmon resonance (LSPR)-based microfluidic optical biosensing is a promising approach to fill this technical gap as it could potentially permit real-time refractometric detection of biomolecular binding on a metallic nanoparticle surface and sensor miniaturization, both leading to rapid and sample-sparing analyte analysis. Despite this promise, practical implementation of such a microfluidic assay for cytokine biomarker detection in serum samples has not been established primarily due to the limited sensitivity of LSPR biosensing. Here, we developed a high-throughput, label-free, multiarrayed LSPR optical biosensor device with 480 nanoplasmonic sensing spots in microfluidic channel arrays and demonstrated parallel multiplex immunoassays of six cytokines in a complex serum matrix on a single device chip while overcoming technical limitations. The device was fabricated using easy-to-implement, one-step microfluidic patterning and antibody conjugation of gold nanorods (AuNRs). When scanning the scattering light intensity across the microarrays of AuNR ensembles with dark-field imaging optics, our LSPR biosensing technique allowed for high-sensitivity quantitative cytokine measurements at concentrations down to 5–20 pg/mL from a 1 μL serum sample. Using the nanoplasmonic biosensor microarray device, we demonstrated the ability to monitor the inflammatory responses of infants following cardiopulmonary bypass (CPB) surgery through tracking the time-course variations of their serum cytokines. The whole parallel on-chip assays, which involved the loading, incubation, and washing of samples and reagents, and 10-fold replicated multianalyte detection for each sample using the entire biosensor arrays, were completed within 40 min.Keywords
Funding Information
- National Center for Advancing Translational Sciences (2UL1TR000433)
- Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET 1263889)
- National Heart, Lung, and Blood Institute (R01 HL119542-01A1)
This publication has 36 references indexed in Scilit:
- The pediatric sepsis biomarker risk modelCritical Care, 2012
- Tight Glycemic Control versus Standard Care after Pediatric Cardiac SurgeryNew England Journal of Medicine, 2012
- Size Matters: Problems and Advantages Associated with Highly Miniaturized SensorsSensors, 2012
- Single Unlabeled Protein Detection on Individual Plasmonic NanoparticlesNano Letters, 2012
- A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cellsNature Medicine, 2011
- Rational Selection of Gold Nanorod Geometry for Label-Free Plasmonic BiosensorsACS Nano, 2009
- Biosensing with plasmonic nanosensorsNature Materials, 2008
- Cytokine profiles as markers of disease severity in sepsis: a multiplex analysisCritical Care, 2007
- Proinflammatory cytokine (IL-1β, IL-6, IL-12, IL-18 and TNF-α) levels in sera of patients with subacute cutaneous lupus erythematosus (SCLE)Immunology Letters, 2006
- Development, validation, and implementation of a multiplex immunoassay for the simultaneous determination of five cytokines in human serumJournal of Pharmaceutical and Biomedical Analysis, 2005